Leukemia, B-Cell: Clinical Trials

3 trials for Leukemia, B-Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Terminated 3

Follow Leukemia, B-Cell: new trials by email Literature Review of Leukemia, B-Cell trials Research Report on Leukemia, B-Cell

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
64Cu-LLP2A for Imaging Hematologic Malignancies
64Cu-LLP2A, PET/CT - Multiple Myeloma, Low-Grade Lymphoma
Early Phase 1TerminatedWashington University School of Medicine212025-03-202026-10-16
Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)
CART 19 - LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Early Phase 1TerminatedUniversity of Pennsylvania202016-01-292023-06-22
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
vincristine - Chronic Lymphocytic Leukemia (CLL)
Early Phase 1TerminatedDartmouth-Hitchcock Medical Center112012-10-012015-05-12

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Lymphoid (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Leukemia, Lymphoid (2)

Interventions

Positron Emission Tomography Computed Tomography (1)  ·  Vincristine (1)

Sponsors

Dartmouth-Hitchcock Medical Center (1)  ·  University of Pennsylvania (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)

Top investigators

Alexey V Danilov, MD (1)  ·  Farrokh Dehdashti, M.D. (1)  ·  Saar Gill, MD (1)

Results publications

PMID 32298202, PMID 35349631

NIH funding

R42CA257797 (1)